[Experiences with high-dosage short-term dithranol therapy of psoriasis]. 1984

H D Göring, and M Voss

Fifty patients with psoriasis were treated with short-term dithranol therapy. This therapy is based upon the different kinetics of penetration of dithranol in healthy and damaged skin. In inpatients once a day 1% dithranol-5% salicylic acid vaseline was applied to all parts of the skin and after 5-10 min washed off thoroughly. Within a few days the dosage was increased to 3% dithranol and the application time to 20 min if possible. The treatment was continued on an individual tolerance basis. In contrast to the in-patients, the out-patients were treated according to plan with weekly increases of dithranol concentration from 1-3% and an application time from 5-20 min. Thirty-two patients (17 in-patients, 15 out-patients) showed a good response, in 12 cases (5 in-patients, 7 out-patients) the response was fair and in 6 cases (2 in-patients, 4 out-patients) the response was poor. Short-term dithranol therapy seems to be superior to the conventional therapy with dithranol. Its advantages are the absence or insignificance of irritability of the healthy skin surrounding the psoriatic plaques, and the economy of time and expense.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000873 Anthracenes A group of compounds with three aromatic rings joined in linear arrangement.
D000875 Anthralin An anthracene derivative that disrupts function and structure of MITOCHONDRIA and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS. 1,8-Dihydroxy-9-anthrone,Dithranol,1,8,9-Anthracenetriol,1,8-Dihydroxy-9(10H)-anthracenone,Anthraforte,Anthranol,Cignolin,Cygnoline,Dihydroxyanthranol,Dithrocream,Ditranol FNA,Lasan,Micanol,Psoradrate,Psoricrème,1,8 Dihydroxy 9 anthrone,FNA, Ditranol

Related Publications

H D Göring, and M Voss
February 1986, Therapeutische Umschau. Revue therapeutique,
H D Göring, and M Voss
January 1983, Dermatologica,
H D Göring, and M Voss
January 1985, Dermatologische Monatschrift,
H D Göring, and M Voss
November 1994, International journal of dermatology,
H D Göring, and M Voss
January 1989, Acta dermato-venereologica,
H D Göring, and M Voss
May 1991, Schweizerische medizinische Wochenschrift,
H D Göring, and M Voss
August 1984, The Journal of rheumatology,
H D Göring, and M Voss
January 1987, Acta dermato-venereologica,
H D Göring, and M Voss
January 1990, Dermatologische Monatschrift,
Copied contents to your clipboard!